In a nutshell This study investigated whether end-of-treatment PET scans could be left out if the mid-treatment scans were negative (no cancer activity). The authors concluded that the end-of-treatment scans were essential, even in patients with negative interim results. Some background Positron emission tomograpy (PET) scans are used to...
Read MorePerformance status-2 – Symptomatic, 50 in bed Posts on Medivizor
ABVD versus Stanford V chemotherapy for early-stage, bulky Hodgkin lymphoma
In a nutshell This trial compared the outcomes of ABVD and Stanford-V chemotherapy in patients with stage I or stage II bulky Hodgkin lymphoma. The authors concluded that both treatments were equally effective. Some background Hodgkin Lymphoma is a cancer of the lymph system. Patients with bulky disease have tumors larger than 10 cm....
Read MoreRadiation therapy after stem-cell transplantation is safe and effective for relapsed- or refractory Hodgkin lymphoma
In a nutshell This study assessed whether patients with relapsed- or refractory Hodgkin Lymphoma should be treated with radiation therapy. The authors concluded that radiation therapy was safe and prevented the return of the disease in certain patients. Some background Hodgkin lymphoma is a cancer of the lymph system. It is a...
Read MoreBleomycin lung toxicity is not associated with the risk of radiation lung injury in Hodgkin lymphoma
In a nutshell This study investigated whether or not there was an increased risk of radiation pneumonitis (RP, radiation-induced lung injury) in Hodgkin lymphoma patients treated with the chemotherapy bleomycin. The authors concluded that there was no association between bleomycin lung effects and RP. Some background...
Read MoreSearching for small-cell lung cancer patients to test pembrolizumab combined with chemotherapy and radiation
In a nutshell This phase 1 trial aims to determine the dosage of the anti-cancer drug pembrolizumab (Keytruda, or MK-3475) and whether it is effective at treating small-cell lung cancer (SCLC) when combined with both chemotherapy and radiation therapy. The main outcome of the trial will be the maximum tolerated dose (MTD – the highest dose of a...
Read MoreDealing with cancer pain: Low-dose morphine examined
In a nutshell This study compared weak opioids and low-dose morphine in providing pain relief for moderate cancer pain. Researchers concluded that low-dose morphine is more suitable as pain management for moderate cancer pain than weaker pain relievers. Some background The guidelines for cancer pain relief developed by the World Health...
Read MoreDealing with cancer pain: Low-dose morphine examined
In a nutshell This study compared weak opioids and low-dose morphine in providing pain relief for moderate cancer pain. Researchers concluded that low-dose morphine is more suitable as pain management for moderate cancer pain than weaker pain relievers. Some background The guidelines for cancer pain relief developed by the World Health...
Read MoreDealing with cancer pain: Low-dose morphine examined
In a nutshell This study compared weak opioids and low-dose morphine in providing pain relief for moderate cancer pain. Researchers concluded that low-dose morphine is more suitable as pain management for moderate cancer pain than weaker pain relievers. Some background The guidelines for cancer pain relief developed by the World Health...
Read MorePaclitaxel-based chemo-radiotherapy in NSCLC patients with tumor following surgery
In a nutshell The authors assessed the effectiveness of paclitaxel (Taxol)-based chemo-radiotherapy (combination of chemotherapy and radiation therapy) in non-small cell lung cancer patients (NSCLC) with presence of tumor after surgery. Some background The primary treatment for NSCLC is the surgical removal of the affected lobe of...
Read MoreBenefits of preventive radiation therapy to the head in stage III-N2 non-small cell lung cancer
In a nutshell The authors evaluated the benefits of preventive radiation therapy in patients with non-small cell lung cancer (NSCLC) who have high risk of developing brain metastases (spreading of cancer from the lungs to the brain). Some background NSCLC is the most common type of lung cancer, accounting for 85% of all lung cancers. In...
Read MoreMaintenance therapy does not impair subsequent treatment with pemetrexed in metastatic lung cancer
In a nutshell The authors aimed to determine whether previous maintenance therapy with gemcitabine or erlotinib impaired pemetrexed treatment. Some background Maintenance therapy is the ongoing use of chemotherapy or another treatment given to help the primary treatment succeed and prevent cancer recurrence. Two drugs have been...
Read MoreDoes endocrine therapy affect sexual function in breast cancer?
In a nutshell This paper studied the impact of endocrine therapy on sexual function in postmenopausal patients with breast cancer. Some background Endocrine therapy is used in the treatment of hormone receptor positive early breast cancer. Hormone receptor positive breast cancer is cancer which has an abundant presence of the estrogen or...
Read More